Biotechnology · Healthcare
CFO, Board Member
2022-01-01–present
Analyst
Private Investor
Board Member
Coya Therapeutics, Inc. (COYA)Equibles does not estimate personal net worth.
David Snyder is recorded as Analyst at Private Investor, Board Member at Coya Therapeutics, Inc. (COYA) since January 1, 2022 and CFO at Coya Therapeutics, Inc. (COYA). The newest filing on record that lists David Snyder as CFO and Board Member at Coya Therapeutics, Inc. (COYA) is dated May 13, 2026. The proxy statement of Coya Therapeutics, Inc. reports total compensation of $1,368,700 for David Snyder in fiscal 2025, including a base salary of $442,000. Disclosed compensation is on record for 5 fiscal years. Coya Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Coya Therapeutics, Inc. includes Arun Swaminathan (CEO and Board Member), Dr. Arun Swaminathan (CEO), Howard Berman (Chairman) and 7 others.
2022-01-01–present
Last confirmed May 13, 2026
Private Investor
Analyst
Source not stated
Start not stated–present
Last confirmed May 13, 2026
Biotechnology · Healthcare
CFO, Board Member
2022-01-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Coya Therapeutics, Inc. (COYA) | Chief Financial Officer and Chief Operating Officer | $442,000 | $1,368,700 |
| 2024 | Coya Therapeutics, Inc. (COYA) | Chief Financial Officer and Chief Operating Officer | $425,000 | $1,465,084 |
| 2023 | Coya Therapeutics, Inc. (COYA) | Chief Financial Officer and Chief Operating Officer | $425,000 | $947,888 |
| 2022 | Coya Therapeutics, Inc. (COYA) | Chief Financial Officer and Chief Operating Officer | $279,775 | $608,521 |
| 2021 | Coya Therapeutics, Inc. (COYA) | Chief Financial Officer and Chief Operating Officer | — | — |
No call appearances or filed executive changes recorded yet.